 |
Press Release
For Immediate Release |
For more information, contact:
|
Dennis Torkko
Executive Vice President
Santal Solutions, LLC
(920) 968-1002
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
|
|
Santal Solutions to Extend Product Distribution to India
Neenah, Wis. (Jan. 3, 2008) — Santal Solutions today announced an agreement with East India Pharmaceutical Works Ltd., under which Santal Solutions will supply its proprietary ingredient OSA™ to EIPW, Kolkata, India.
OSA™ is a proprietarily processed virgin isolate aqueous extract of the Gymnema sylvestre leaf, a plant that grows naturally in the Indian subcontinent. OSA™ is supported by extensive cellular level research and human clinicals.
“We are delighted to be working with one of the oldest pharmaceutical companies in India,” said Arun K. Chatterji, Ph.D., Santal Solutions president and CEO. “Our premium ingredient OSA™ will give impetus to the marketing strategies of EIPW in India and provide a boost to our growing global market share.”
“This distribution agreement with Santal Solutions gives us access to a superior ingredient that will be used in several of our product formulations,” said Dipankar Dutta
Gupta, managing director of EIPW.
###
Located in Neenah, Wis., Santal Solutions provides consumers and manufacturing partners with natural, premium quality products made with scientifically proven ingredients. Media relations, advertising and publicity contact: Kristen Schremp at
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
or 703.928.5527. Based in Kolkata, India, East India Pharmaceutical Works Ltd. has three manufacturing units, a work force of 1,500 employees, and an annual turnover of approximately Rs. 800 million. EIPW is ISO 9001-2000 certified.
|
|
